IARC News
IARC
Three Common Medicines Classified as Carcinogenic by IARC: What Patients Need to Know Before Stopping Treatment
Hydrochlorothiazide, voriconazole and tacrolimus have been placed in IARC’s Group 1 category, but the classification identifies a cancer hazard not the individual cancer risk faced by every patient taking these medicines